DexCom Inc. stock rises Tuesday, still underperforms market

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.

American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA

CRO to Incorporate DEXCOM's Continuous Glucose Monitoring "CGM" Technology In the GlucoGuard Multi Patient StudyDel Mar, California--(Newsfile Corp. - April 1, 2026) - American Diversified Holdings ...
Yahoo

The Dexcom Continuous Glucose Monitor Receiver Recall: What You Need to Do to Stay Safe

Add Yahoo as a preferred source to see more of our stories on Google. Your device's unique device identifier and model number are on the back of your receiver. Some of Dexcom's continuous glucose ...
CNBC

Dexcom shares plummet almost 40% after company misses on revenue, lowers guidance

Dexcom shares plunged on disappointing revenue and weak guidance. The stock was down 13% for the year as of Thursday's close. Dexcom makes continuous glucose monitors for patients with diabetes. In ...

DexCom Inc. stock underperforms Friday when compared to competitors

Shares of DexCom Inc. slid 5.81% to $62.25 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.67% to 6,368.85 and Dow Jones ...

How The DexCom (DXCM) Investment Story Is Shifting As Analyst Targets Diverge

DexCom’s fair value price target has been tweaked from US$85.85 to US$86.12 per share, a small shift that still matters if ...
Yahoo

Dexcom recalls G6 CGM app over software problem

Add Yahoo as a preferred source to see more of our stories on Google. Dexcom recalled an Android app for its G6 continuous glucose monitor because of a problem with the app stopping unexpectedly.

Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure?

If you are wondering whether DexCom at around US$64 a share looks appealing or expensive, this article breaks down what that price might actually represent for you. The stock has been under pressure ...
The Motley Fool

Where Will DexCom Be in 5 Years?

DexCom will likely make significant headway in its addressable market in the next five years. The company should also increase its reach by launching new products and entering new countries. Despite a ...
The Motley Fool

3 Reasons to Buy DexCom Stock Like There's No Tomorrow

DexCom's devices are incredibly valuable to diabetes patients. The company should continue to increase its addressable market. The stock's valuation looks as reasonable as it has in almost three years ...
CNBC

Dexcom says the outage that kept diabetes patients from tracking blood sugar was a 'complete surprise'

Dexcom experienced it's largest ever technical glitch over the weekend. The company's technology chief acknowledged that Dexcom needs to do better. Dexcom is analyzing its tech infrastructure and ...